Genmab A/S Files 6-K Report for December 2024
Ticker: GNMSF · Form: 6-K · Filed: Dec 3, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Dec 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Genmab A/S filed a 6-K for Dec 2024, incorporating into existing S-8 filings. Standard reporting.
AI Summary
Genmab A/S filed a Form 6-K on December 3, 2024, to report information for the month of December 2024. This report is incorporated by reference into Genmab A/S's existing S-8 registration statements (File Nos. 333-232693, 333-253519, 333-262970, and 333-277273). The company's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Why It Matters
This filing serves as an update for investors and indicates that Genmab A/S is fulfilling its reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer to incorporate information into existing registration statements, with no new material financial or operational information disclosed.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The purpose of this Form 6-K is to report information for the month of December 2024 and to be incorporated by reference into Genmab A/S's existing registration statements on Form S-8.
What are the file numbers for the Genmab A/S registration statements on Form S-8 mentioned in the filing?
The mentioned file numbers for Genmab A/S's registration statements on Form S-8 are 333-232693, 333-253519, 333-262970, and 333-277273.
Where are Genmab A/S's principal executive offices located?
Genmab A/S's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
What type of filing is this Form 6-K?
This is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Under which act is Genmab A/S filing this report?
Genmab A/S is filing this report under the Securities Exchange Act of 1934.
Filing Stats: 233 words · 1 min read · ~1 pages · Grade level 15.4 · Accepted 2024-12-03 11:19:02
Filing Documents
- tmb-20241203x6k.htm (6-K) — 18KB
- tmb-20241203xex99d1.htm (EX-99.1) — 167KB
- tmb-20241203xex99d1001.jpg (GRAPHIC) — 5KB
- 0001558370-24-015978.txt ( ) — 193KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF DECEMBER 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. nthony GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: DECEMBER 3, 2024 EXHIBIT INDEX O Exhibit Description of Exhibit 99.1 Company Announcement Dated December 3, 2024: Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons